Mumbai, India , is rapidly emerging as a significant hub for the creation of Lenacapavir Sodium API (CAS 2189684-53-3). Several firms have established substantial manufacturing units focusing on this essential antiviral drug . Identifying the precise top manufacturers can be complex due to fluctu